YY/T 1227-2014In vitro diagnostic reagent(kit)nomenclature for clinical chemistry (English PDF)
临床化学体外诊断试剂(盒)命名
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1227-2014 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
June 17, 2014
Implementation date
July 1, 2015
Scope
YY/T 1227-2014 is the English-translated version of 临床化学体外诊断试剂(盒)命名.
YY/T 1227-2014 is the Chinese pharmaceutical industry standard that fixes the principles by which an in vitro diagnostic reagent kit for clinical chemistry is named, and gives worked examples of the names of a number of such products.
It sets out the scope, the normative references, the terms and definitions and the requirements the name must satisfy, so that the products of this field are named consistently. Issued on 17 June 2014, it has applied since 1 July 2015.
Found what you need?
Document preview — YY/T 1227-2014
National Standard of the People's Republic of China
- ICS
- 11.100
- Classification
- C 44
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- Introduction
- 1 Scope
- 2 Normative references
- 3 Terms and Definitions
Foreword
This standard was drafted in accordance with GB/T 1.1-2009 given rules.
Introduction
This standard is based on a lot of research carried out on the basis of the State Food and Drug Administration issued the "in vitro diagnostic reagents Registry After (Trial) "(SFDA [2007] No. 229), repeatedly seek expert advice in clinical, manufacturing, regulatory and other aspects of development. needle For the spectrophotometric principle, the use of automatic biochemical analyzer, spectrophotometer or semi-automatic biochemical analyzer, medical laboratory In vitro diagnostic reagents clinical chemistry project quantitative test used (box).
The purpose of this is to develop standards of in vitro diagnostic reagents product names provide a reference for manufacturers, for regulators regulate markets Basis, in order to standardize in vitro diagnostic reagents product name to facilitate clinical use. Clinical chemistry in vitro diagnostic reagents (box) named
1 Scope
This standard specifies the principles of clinical chemistry in vitro diagnostic kit named to be followed, and part of the project to develop a specific named instance.
This standard contains the scope, normative references, terms and definitions and requirements and so on.
This standard applies to the use of spectrophotometry using automatic biochemical analyzer, spectrophotometer or semi-automatic biochemical analyzer, medical Laboratory for quantitative detection of clinical chemistry in vitro diagnostic reagents (box) products. This standard does not apply to calibration, controls.
2 Normative references
The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein Member. For undated references, the latest edition (including any amendments) applies to this document.
ISO 18113-1:2009 In vitro diagnostic medical device manufacturers to provide information (labeling) - Part 1. Terms, definitions and general Requirements (Invitrodiagnosticmedicaldevices-Informationsuppliedbythemanufacturer (labeling) - Part 1. Terms, definitionsandgeneralrequirements)
3 Terms and Definitions
The following terms and definitions apply to this document.
3.1 IVD invitrodiagnosticreagent
It intended by the manufacturer to be used for in vitro diagnostic medical devices for chemical, biological or immunological components, solutions or preparation. [ISO 18113-1:2009, definitions 3.28]
3.2 In vitro diagnostic reagent (kit) for clinical chemistry
On automatic biochemical analyzer, semi-automatic biochemical analyzer or spectrophotometer chemical detection of human body fluids and life related activities Quality, to provide clinical diagnosis, treatment, diagnostic kits observe the condition, health assessment and other information.
3.3 Analyte (analyte) analyte measured
Component having a measurable property of the sample.
Example: In the "plasma glucose concentration of the substance", the "glucose" analyte "concentration" feature. [Adapted from GB/T 21415-2008/ISO 17511:2003, 3.2 Definition]
3.4 Intended use
In vitro diagnostic manufacturers specifications, instructions for use and in vitro diagnostic manufacturers to provide information about the given product, process or service Operational objectives intended to be used for. [ISO 18113-1:2009, definitions 3.31]
Note: in vitro diagnostic label may include a description of the intended use of two parts, the description of the function in vitro diagnostic medical devices (for example, a serum or […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Referenced standards
Normative references
ISO 18113-1:2009
Similar standards
How to Download YY/T 1227-2014
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Fast delivery
After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0463-2026 — Dentistry - Refractory investment and die materials
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
YY/T 1227-2014
$235.00